When to Order Imaging for Cerebrovascular Disease: ACR Appropriateness Decoded

When to Order Imaging for Cerebrovascular Disease: ACR Appropriateness Decoded

It’s 2 AM in the emergency department. A 72-year-old patient presents with acute-onset right-sided weakness and aphasia. The clock is ticking. You suspect an ischemic stroke, but you need to rule out a hemorrhage before considering thrombolysis. Do you order a non-contrast CT of the head, a CTA of the head and neck, or an MRI/MRA? Making the right choice quickly is critical for patient outcomes. This guide decodes the American College of Radiology (ACR) Appropriateness Criteria for cerebrovascular disease, providing a clear, evidence-based framework for these common and high-stakes clinical decisions.

What Does the ACR Guideline for Cerebrovascular Disease Cover?

The ACR Appropriateness Criteria for Cerebrovascular Disease addresses the diagnostic imaging of patients with suspected or known conditions affecting the blood vessels of the brain and neck. This includes a range of clinical scenarios, from the evaluation of an asymptomatic patient with a cervical bruit to the hyperacute workup of a suspected stroke. The guidelines are designed to help clinicians select the most appropriate imaging modality based on the specific clinical presentation, balancing diagnostic yield with risks such as radiation exposure and contrast administration.

This document specifically covers ischemic stroke, transient ischemic attack (TIA), parenchymal hemorrhage, and suspected dural venous sinus thrombosis. It does not cover imaging for unruptured intracranial aneurysms, arteriovenous malformations (AVMs), or post-treatment follow-up, which are addressed in separate ACR guidelines. The focus here is on the initial diagnostic pathway for common cerebrovascular events.

What Imaging Should I Order for Cerebrovascular Disease? Recommendations by Clinical Scenario

Choosing the right initial imaging study depends entirely on the patient’s symptoms and the suspected underlying pathology. The ACR provides detailed guidance for several common clinical variants.

For an asymptomatic patient with a structural lesion on physical examination (e.g., a cervical bruit) or significant risk factors, non-invasive vascular imaging is the primary approach. The ACR rates US duplex Doppler carotid artery, MRA of the neck (with or without contrast), and CTA of the neck with IV contrast as Usually appropriate. Ultrasound is an excellent initial screening tool as it involves no radiation. CTA and MRA provide more comprehensive anatomical detail of the entire cervicocerebral vasculature.

In a patient presenting with a carotid territory or vertebrobasilar TIA, for an initial screening survey, the focus shifts to evaluating both the brain parenchyma and the vasculature. Brain MRI (without or with contrast) and non-contrast head CT are Usually appropriate to look for evidence of infarction. To assess the vessels, MRA of the head and neck (with or without contrast) and CTA of the head and neck are also rated Usually appropriate. The combination of brain and vessel imaging is key to identifying the cause of the TIA and guiding secondary prevention.

For a new focal neurologic defect, fixed or worsening, within 6 hours of onset (suspected stroke), the guidelines are nearly identical to those for a presentation longer than 6 hours. The immediate priority is to rule out hemorrhage. Therefore, a non-contrast CT of the head is Usually appropriate and often the fastest and most accessible first step. Brain MRI is also Usually appropriate and is more sensitive for detecting early ischemic changes. To evaluate for large vessel occlusion (LVO) as a target for thrombectomy, CTA or MRA of the head and neck are also Usually appropriate. Perfusion imaging (CT or MRI) May be appropriate to assess the extent of salvageable brain tissue (penumbra), particularly in patients outside the standard treatment window.

When there is a proven parenchymal hemorrhage (hematoma) on initial imaging, the goal becomes identifying an underlying cause, such as an aneurysm, AVM, or venous thrombosis. Non-contrast CT is Usually appropriate for follow-up to assess for hematoma expansion. To evaluate the vasculature, CTA head, CTV head, and MRA head are all rated Usually appropriate. Conventional arteriography, an invasive study, May be appropriate if a vascular malformation is suspected based on non-invasive imaging.

Finally, for suspected dural venous sinus thrombosis, a condition that can present with headache, seizures, or focal deficits, specific venous imaging is required. MRV (magnetic resonance venography) of the head, with or without contrast, is Usually appropriate and is often considered the gold standard. CTV (CT venography) is also Usually appropriate and can be a rapid alternative. A baseline non-contrast CT head or brain MRI is also Usually appropriate to assess for secondary signs like venous infarcts or hemorrhage.

ACR Imaging Recommendations Table for Cerebrovascular Disease

Adult vs. Pediatric Cerebrovascular Disease Imaging: Radiation Dose Tradeoffs

While cerebrovascular disease is more common in adults, it can occur in children due to conditions like sickle cell disease, congenital heart disease, or trauma. The ACR guidelines provide pediatric-specific relative radiation level (RRL) estimates, reflecting the critical importance of the ALARA (As Low As Reasonably Achievable) principle in this population. Children have a longer life expectancy over which the potential stochastic effects of radiation can manifest, and their developing tissues are more radiosensitive than those of adults.

For this reason, non-ionizing modalities like MRI, MRA, and ultrasound are often preferred in pediatric patients when clinically appropriate. When CT is necessary, pediatric-specific protocols that adjust technical parameters (e.g., kVp, mAs) are essential to minimize the dose. For example, a CTA of the head and neck in a child carries an RRL of ☢ ☢ ☢ ☢ (3-10 mSv), while the adult dose is often in the ☢ ☢ ☢ (1-10 mSv) range, highlighting that while the dose range overlaps, careful protocoling is paramount. These considerations underscore the need to justify every imaging study involving ionizing radiation in children and to select the test that provides the necessary diagnostic information with the lowest possible risk.

Imaging Protocol Details for Cerebrovascular Disease

Once you’ve decided on the right study based on the clinical scenario, ensuring it is performed correctly is the next critical step. The specific imaging protocol—including slice thickness, contrast timing, and specific MRI sequences—can significantly impact diagnostic quality. Our library of protocol guides provides detailed, practical information for the key studies recommended in these ACR criteria.

• US Carotid Doppler
• MRA Neck With and Without Contrast
• MRA Brain Without Contrast (3D TOF)
• CT Brain Without Contrast

Tools to Help You Order the Right Study

Navigating imaging guidelines in the middle of a busy shift can be challenging. To streamline this process, several digital tools can help you apply evidence-based criteria at the point of care, ensuring you select the most appropriate study for your patient while considering factors like radiation dose.

The ACR Appropriateness Criteria Lookup tool provides a searchable interface for the full library of ACR guidelines, extending far beyond cerebrovascular disease. It allows you to quickly find recommendations for hundreds of clinical scenarios you may encounter.

For a deeper dive into how these studies are performed, the Imaging Protocol Library offers detailed, step-by-step guides. These are invaluable for trainees and any clinician looking to understand the technical aspects of the imaging they are ordering.

To help with patient communication and tracking cumulative exposure, the Radiation Dose Calculator provides estimates for common diagnostic exams. This can be a useful aid when discussing the risks and benefits of imaging with patients and their families, particularly when multiple studies are required.

Why is a non-contrast CT head the first test for most suspected acute strokes?

A non-contrast head CT is extremely fast and highly sensitive for detecting acute hemorrhage. The most critical initial decision in a stroke workup is to differentiate between an ischemic stroke (a clot) and a hemorrhagic stroke (a bleed). The treatments are completely different; giving thrombolytics (“clot-busters”) to a patient with a hemorrhage can be catastrophic. A non-contrast CT can definitively rule out hemorrhage in minutes, clearing the way for potential thrombolytic therapy.

When is MRA preferred over CTA for evaluating cerebrovascular disease?

MRA is often preferred over CTA in several situations. First, for patients in whom radiation exposure is a significant concern, such as children, young adults, or pregnant women, MRA is the ideal choice as it uses no ionizing radiation. Second, for patients with a severe allergy to iodinated contrast or with significant renal impairment, MRA (which can often be done without contrast or with a gadolinium-based agent) is a safer alternative. Finally, MRI/MRA can provide superior detail of the brain parenchyma, making it better for detecting small or early ischemic strokes alongside the vascular assessment.

What is the role of perfusion imaging (CTP/MRP) in acute stroke?

Perfusion imaging, whether by CT (CTP) or MRI (MRP), is used to identify the “ischemic penumbra.” This is an area of brain tissue that is ischemic (has low blood flow) and at risk of dying, but is not yet irreversibly infarcted (the “infarct core”). By comparing the volume of the penumbra to the core, clinicians can identify patients who may benefit from endovascular thrombectomy, even if they present outside the traditional 6-hour treatment window. A large penumbra with a small core suggests a significant amount of salvageable brain tissue.

For a suspected TIA, is it necessary to image both the head and neck?

Yes, imaging both the head (intracranial) and neck (extracranial) is generally recommended in the workup of a TIA. The goal is twofold: first, to use brain imaging (preferably MRI with DWI) to confirm if a small infarct occurred, and second, to use vascular imaging (CTA, MRA, or carotid ultrasound) to identify the source of the TIA. A common cause is an embolus from a stenotic carotid artery in the neck, and identifying and treating this stenosis is critical for secondary stroke prevention.

Why is conventional arteriography rated ‘Usually not appropriate’ for initial screening?

Conventional catheter arteriography is an invasive procedure that involves inserting a catheter into an artery (usually the femoral artery) and advancing it to the cervicocerebral vessels to inject contrast under fluoroscopy. While it provides the highest spatial resolution and is considered the gold standard for vessel imaging, it carries a small but significant risk of complications, including stroke, vessel dissection, and access site bleeding. Given the excellent quality and safety of non-invasive alternatives like CTA and MRA, conventional arteriography is reserved for cases where non-invasive tests are inconclusive or when an immediate endovascular intervention is planned.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026